Literature DB >> 10845612

Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells.

H Sone1, B K Deo, A K Kumagai.   

Abstract

PURPOSE: To investigate effects of vascular endothelial growth factor (VEGF) on glucose transport and GLUT1 glucose transporter expression in primary bovine retinal endothelial cell (BREC) cultures.
METHODS: Glucose transport in control and VEGF-treated BREC cultures was determined by measurement of [14C]-3-O-methylglucose (3MG) uptake. GLUT1 protein and mRNA was determined by Western and Northern blot analyses, respectively. Protein kinase C (PKC) activity was measured in control and VEGF-treated cultures, and glucose transport was determined with and without prior PKC depletion and PKC inhibition.
RESULTS: Dose-dependent increases in 3MG uptake were seen in the VEGF-treated cultures, with an increase of 69% after a 24-hour exposure to 50 ng/ml VEGF (P < 0.001). Total cellular GLUT1 mRNA or protein, however, was unchanged. Western blot analysis of plasma membrane fractions revealed a 75% increase in plasma membrane GLUT1 in VEGF-treated cultures (P = 0.02), suggesting that the VEGF-stimulated increase in glucose transport was due to a translocation of GLUT1 to the cell membrane. VEGF stimulated a 90% increase in PKC activity in membrane fractions from cultures treated with VEGF, and VEGF-stimulated enhancement of glucose transport was abolished by cellular PKC depletion and by general and PKC beta inhibition.
CONCLUSIONS: The present study demonstrates VEGF-mediated enhancement of retinal endothelial cell glucose transport and suggests that this increase is due to PKC beta-mediated translocation of cytosolic GLUT1 to the plasma membrane surface. Upregulation of retinal endothelial cell glucose transport by various factors associated with the development of retinopathy may be responsible for the metabolic derangements observed in the diabetic inner blood-retinal barrier in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845612

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  30 in total

1.  Dietary blueberry supplementation affects growth but not vascularization of neural transplants.

Authors:  Lauren M Willis; Brent J Small; Paula C Bickford; Claudia D Umphlet; Alfred B Moore; Ann-Charlotte E Granholm
Journal:  J Cereb Blood Flow Metab       Date:  2008-02-20       Impact factor: 6.200

Review 2.  Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy.

Authors:  Eain M Cornford; Shigeyo Hyman
Journal:  NeuroRx       Date:  2005-01

Review 3.  Will the original glucose transporter isoform please stand up!

Authors:  Anthony Carruthers; Julie DeZutter; Amit Ganguly; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-18       Impact factor: 4.310

4.  Beta interferon regulation of glucose metabolism is PI3K/Akt dependent and important for antiviral activity against coxsackievirus B3.

Authors:  J D Burke; L C Platanias; E N Fish
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

5.  miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1.

Authors:  Hongbao Guo; Yang Nan; Yingwei Zhen; Yahui Zhang; Liyun Guo; Kai Yu; Qiang Huang; Yue Zhong
Journal:  Tumour Biol       Date:  2016-07-31

6.  Acute modulation of sugar transport in brain capillary endothelial cell cultures during activation of the metabolic stress pathway.

Authors:  Anthony J Cura; Anthony Carruthers
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

7.  Antiangiogenic activity of 2-deoxy-D-glucose.

Authors:  Jaime R Merchan; Krisztina Kovács; Jaclyn W Railsback; Metin Kurtoglu; Yuqi Jing; Yolanda Piña; Ningguo Gao; Timothy G Murray; Mark A Lehrman; Theodore J Lampidis
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

8.  Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.

Authors:  Viktor R Drel; Pal Pacher; Tayyeba K Ali; Jeho Shin; Ulrich Julius; Azza B El-Remessy; Irina G Obrosova
Journal:  Int J Mol Med       Date:  2008-06       Impact factor: 4.101

Review 9.  Models of retinal diseases and their applicability in drug discovery.

Authors:  Goldis Malek; Julia Busik; Maria B Grant; Mayur Choudhary
Journal:  Expert Opin Drug Discov       Date:  2018-01-30       Impact factor: 6.098

10.  Developmentally spliced PKCbetaII provides a possible link between mTORC2 and Akt kinase to regulate 3T3-L1 adipocyte insulin-stimulated glucose transport.

Authors:  E Kleiman; G Carter; T Ghansah; N A Patel; D R Cooper
Journal:  Biochem Biophys Res Commun       Date:  2009-08-15       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.